Inhibition of arachidonic acid metabolism decreases tumor cell invasion and matrix metalloproteinase expression

详细信息    查看全文

• 作者：Sittichai Koontongkaew ; Paopanga Monthanapisut ; Theeranuch Saensuk
• 关键词：NSAIDs ; COX ; LOX ; Aspirin ; Sulindac ; NS-398 ; NDGA ; ETYA ; MMPs ; Cell invasion ; Head and neck cancer ; Colon cancer
• 刊名：Prostaglandins and Other Lipid Mediators
• 出版年：2010
• 出版时间：November 2010
• 年：2010
• 卷：93
• 期：3-4
• 页码：100-108
• 全文大小：1231 K

文摘

Head and neck cancers are known to synthesize arachidonic acid metabolites. Interfering with arachidonic acid metabolism may inhibit growth and invasiveness of cancer cells. In this study we investigate effects of sulindac (the non-selective COX inhibitor), aspirin (the irreversible, preferential COX-1 inhibitor), NS-398 (the selective COX-2 inhibitor), NDGA (nordihydroguaiaretic acid, the selective LOX inhibitor) and ETYA (5,8,11,14-eicosatetraynoic acid, the COX and LOX inhibitor) on cell viability, MMP-2 and MMP-9 activities, and in vitro invasion of cancer cells derived from primary and metastatic head and neck, and colon cancers. The inhibitors of COX and/or LOX could inhibit cell proliferation, MMP activity and invasion in head and neck and colon cancer cells. However, the inhibitory effect was obviously observed in colon cancer cells. Inhibition of arachidonic acid metabolism caused a decrease in cancer cell motility, which partially explained by the inhibition of MMPs. Therefore, COX and LOX pathways play important roles in head and neck cancer cell growth.